Publications by authors named "Susan L Strum"

Claim this Profile
A
A Signature of Pre-Operative Biomarkers of Cellular Senescence to Predict Risk of Cardiac and Kidney Adverse Events after Cardiac Surgery.
Amy Entwistle, Susan Walker, Anne Knecht, Susan L Strum, Asad A Shah

Cardiol Cardiovasc Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling an integrated network of cellular senescence and immune resilience measures in natural aging: a prospective multi-cohort study.
Natalia Mitin, Amy Entwistle, Anne Knecht, Susan L Strum, Allison Ross

medRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A signature of pre-operative biomarkers of cellular senescence to predict risk of cardiac and kidney adverse events after cardiac surgery.
Amy Entwistle, Susan Walker, Anne Knecht, Susan L Strum, Asad Shah

medRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.
Natalia Mitin, Kirsten A Nyrop, Susan L Strum, Anne Knecht, Lisa A Carey

NPJ Breast Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of p16 is a biomarker of chondrocyte aging but does not cause osteoarthritis.
Brian O Diekman, Garrett A Sessions, John A Collins, Anne K Knecht, Susan L Strum

Aging Cell· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of selective small molecule type III phosphatidylinositol 4-kinase alpha (PI4KIIIα) inhibitors as anti hepatitis C (HCV) agents.
Anna L Leivers, Matthew Tallant, J Brad Shotwell, Scott Dickerson, Martin R Leivers, Susan L Strum

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,3,5-Trisubstituted pyridines as selective AKT inhibitors-Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity.
Hong Lin, Dennis S Yamashita, Jin Zeng, Ren Xie, Wenyong Wang, Susan L Strum

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.
Dirk A Heerding, Nelson Rhodes, Jack D Leber, Tammy J Clark, Richard M Keenan, Susan L Strum

J Med Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity.
Nelson Rhodes, Dirk A Heerding, Derek R Duckett, Derek J Eberwein, Victoria B Knick, Susan L Strum

Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis